DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference

WILMINGTON, Mass., March 23, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), previously announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the 2012 Maxim Group Growth Conference on Monday, March 26, 2012 at the Grand Hyatt Hotel in New York City. The time of the presentation, initially scheduled for 4:00 p.m. EDT has been changed to 3:30pm EDT. Interested parties can click here to access the live audio webcast of the presentation or visit our website at www.dusapharma.com. An archived version of the presentation will be available on the DUSA website approximately six hours following the presentation.